What is Insulet Corporation's Market Cap?

Insulet Corporation's Market Cap is $10.3B, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Enterprise Value?

Insulet Corporation's Enterprise Value is $10.7B, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Trailing P/E?

Insulet Corporation's Trailing P/E is 27.5×, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Price / Sales?

Insulet Corporation's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's EV / Revenue?

Insulet Corporation's EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's EV / EBITDA?

Insulet Corporation's EV / EBITDA is 17.5×, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Revenue (TTM)?

Insulet Corporation's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Net Income (TTM)?

Insulet Corporation's Net Income (TTM) is $375.3M, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's EBITDA?

Insulet Corporation's EBITDA is $615.0M, based on as-reported figures from SEC (XBRL) filings.

What is Insulet Corporation's Diluted EPS (TTM)?

Insulet Corporation's Diluted EPS (TTM) is 5.41, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Insulet Corporation

XNAS · usd

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG001SRF439

149.01▲ 0.89 (0.60%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 148.12
Day's Range: 145.00 – 149.69
52-Week Range: 126.40 – 354.88
Volume: 797.0K
Avg Volume: 1.5M

Share Statistics

Shares Outstanding
Employees: 5,400
Exchange: XNAS
Listed: 2007-05-15

Share count as of July 29, 2026

Insulet Corporation (PODD) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Insulet Corporation (PODD)

What is Insulet Corporation's Market Cap?: Insulet Corporation's Market Cap is $10.3B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Enterprise Value?: Insulet Corporation's Enterprise Value is $10.7B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Trailing P/E?: Insulet Corporation's Trailing P/E is 27.5×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Price / Sales?: Insulet Corporation's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EV / Revenue?: Insulet Corporation's EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EV / EBITDA?: Insulet Corporation's EV / EBITDA is 17.5×, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Revenue (TTM)?: Insulet Corporation's Revenue (TTM) is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Net Income (TTM)?: Insulet Corporation's Net Income (TTM) is $375.3M, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's EBITDA?: Insulet Corporation's EBITDA is $615.0M, based on as-reported figures from SEC (XBRL) filings.
What is Insulet Corporation's Diluted EPS (TTM)?: Insulet Corporation's Diluted EPS (TTM) is 5.41, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · PODDAs-filed SEC (XBRL) data